<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>Levothyroxine - Biopharmaceutics Profile</title>
  <style>
    body {
      font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
      background-color: #f5f7fa;
      margin: 0;
      padding: 20px;
      line-height: 1.6;
    }

    .container {
      background-color: #ffffff;
      padding: 40px;
      max-width: 960px;
      margin: auto;
      border-radius: 10px;
      box-shadow: 0 8px 24px rgba(0, 0, 0, 0.08);
    }

    h1 {
      font-size: 26px;
      color: #2c3e50;
      text-align: center;
      margin-bottom: 10px;
    }

    h2 {
      color: #1a5276;
      border-bottom: 2px solid #3498db;
      padding-bottom: 5px;
      margin-top: 40px;
    }

    h3, h4 {
      color: #2c3e50;
      margin-top: 20px;
    }

    p {
      margin: 10px 0;
    }

    table {
      width: 100%;
      border-collapse: collapse;
      margin: 20px 0;
    }

    th, td {
      border: 1px solid #ccc;
      padding: 10px;
      vertical-align: top;
    }

    th {
      background-color: #3498db;
      color: #fff;
      font-weight: 600;
    }

    ul, ol {
      margin-top: 10px;
      padding-left: 20px;
    }

    .footer {
      text-align: center;
      margin-top: 50px;
      font-size: 0.9em;
      color: #777;
    }

    .section-title {
      text-align: center;
      font-size: 20px;
      margin-top: 40px;
      font-weight: 600;
      color: #2c3e50;
    }
  </style>
</head>
<body>
  <div class="container">
    <h1>Levothyroxine - Biopharmaceutics Profile</h1>

    <h3><b>Active Ingredient:</b> Levothyroxine</h3>
    <h3><b>Drug Category:</b> Prescription Only</h3>

    <h2>1. Product Description</h2>
    <table>
      <tr>
        <th>Sr No.</th>
        <th>Brand Name</th>
        <th>Manufacturer</th>
        <th>Dosage Form</th>
        <th>Strength</th>
        <th>Price</th>
      </tr>
      <tr><td>1</td><td>Thyronorm</td><td>Abbott</td><td>Tablet</td><td>75 mcg, 100 mcg</td><td>181.01</td></tr>
      <tr><td>2</td><td>Thyroxine</td><td>GSK</td><td>Tablet</td><td>25 mcg, 50 mcg</td><td>240.00</td></tr>
      <tr><td>3</td><td>Ecithyrox</td><td>Merck</td><td>Tablet</td><td>100 mcg</td><td>2200–3700</td></tr>
    </table>

    <h2>2. Storage Instructions</h2>
    <ul>
      <li>Store at room temperature (25–30°C).</li>
      <li>Protect from light and moisture.</li>
      <li>Keep out of reach of children.</li>
    </ul>

    <h2>3. Chemistry of Drug</h2>
    <p><strong>Chemical Class:</strong> Hormones</p>

    <h2>4. Pharmacokinetics</h2>
    <table>
      <tr><th>Absorption</th><td>50%–80% orally; may decrease with age.</td></tr>
      <tr><th>Distribution</th><td>99% protein-bound (TBG, TBPA, TBA); Vd: 8.7–9.7 L/kg; does not cross placental barrier.</td></tr>
      <tr><th>Metabolism</th><td>Sequential deiodination in liver; conjugated with glucuronides/sulfates; enterohepatic circulation.</td></tr>
      <tr><th>Elimination</th><td>Renal and fecal; 20%–70% excreted in stool; urinary excretion decreases with age.</td></tr>
      <tr><th>Half-life</th><td>Approximately 6–7 days.</td></tr>
    </table>

    <h2>5. Clinical Pharmacology</h2>
    <p><strong>Pharmacological Class:</strong> Hormones</p>
    <table>
      <tr>
        <th>Mechanism of Action (MOA)</th>
        <td>Levothyroxine regulates gene transcription and protein synthesis by binding thyroid hormone receptors in the nucleus (T3/T4), initiating mRNA synthesis.</td>
      </tr>
      <tr>
        <th>Contraindications</th>
        <td>
          <ul>
            <li>Uncorrected adrenal insufficiency</li>
            <li>Untreated thyrotoxicosis</li>
            <li>Acute myocardial infarction</li>
            <li>Hypersensitivity</li>
          </ul>
        </td>
      </tr>
      <tr>
        <th>Precautions</th>
        <td>
          <ul>
            <li>Use cautiously in cardiovascular disease.</li>
            <li>Monitor closely during pregnancy and lactation.</li>
          </ul>
        </td>
      </tr>
    </table>

    <h2>6. Indications</h2>
    <ul>
      <li>Treatment of hypothyroidism</li>
      <li>Suppression of TSH in thyroid cancer and nodules</li>
    </ul>

    <h2>7. Dose Adjustment</h2>
    <p>Required during pregnancy or in elderly patients with comorbidities.</p>

    <h2>8. Adverse Drug Reactions (ADRs)</h2>
    <table>
      <tr><th>General</th><td>Fatigue, increased appetite, weight loss</td></tr>
      <tr><th>CNS</th><td>Headache, nervousness, anxiety</td></tr>
      <tr><th>Musculoskeletal</th><td>Tremors, muscle spasms</td></tr>
      <tr><th>Respiratory</th><td>Dyspnea</td></tr>
      <tr><th>GIT</th><td>Diarrhea, abdominal cramps, vomiting</td></tr>
    </table>

    <h2>9. Drug-Drug Interactions</h2>
    <h4>Reduced T4 Absorption With:</h4>
    <ul>
      <li>Phosphate binders</li>
      <li>Orlistat</li>
      <li>Proton pump inhibitors (PPIs)</li>
      <li>Bile acid sequestrants</li>
    </ul>

    <h4>Altered Metabolism With:</h4>
    <ul>
      <li>Phenobarbital</li>
      <li>Rifampin</li>
    </ul>

    <h2>10. Drug-Food Interactions</h2>
    <ul>
      <li>Soy, walnuts, cottonseed meal, and high-fiber diets reduce absorption.</li>
      <li>Grapefruit juice lowers bioavailability.</li>
    </ul>

    <h2>References</h2>
    <ol>
      <li>Thyronorm Product Leaflet</li>
      <li>“Pharmacology” by Lynn Wecker</li>
      <li>“Clinical Pharmacology and Therapeutics” by James M. Ritels (8th Ed.)</li>
    </ol>

    <div class="footer">
      School of Pharmacy, UMT-SPH<br>
      Course Instructor: Saba Ashraf
    </div>
  </div>
</body>
</html>
